Exclusive: FDA enforcement actions plummet under Trump
FDA actions that safeguard clinical trials, food and drug safety in steep decline, Science investigation reveals
Science Fund for Investigative Reporting
-
-
Exclusive: Major U.S. cancer center ousts ‘Asian’ researchers after NIH flags their foreign ties
Chinese American community fears ethnic targeting at MD Anderson by the Federal Bureau of Investigation and National Institutes of Health -
The war on ‘prediabetes’ could be a boon for pharma—but is it good medicine?
A third of Americans are considered prediabetic—but many may be better off without treatment -
Private research funders court controversy with billions in secretive investments
Critics say offshore investing by high-minded foundations shores up a nefarious system -
Meta-analyses were supposed to end scientific debates. Often, they only cause more controversy
Compiling the evidence from dozens of studies doesn't always bring clarity -
Hidden conflicts? Pharma payments to FDA advisers after drug approvals spark ethical concerns
Science investigation of journal disclosures and pharmaceutical funding records shows potential influence on physician gatekeepers -
FDA’s revolving door: Companies often hire agency staffers who managed their successful drug reviews
Job changes raise conflict of interest questions -
Famed cancer biologist allegedly sexually harassed women for decades
As Inder Verma soared at Salk Institute, women say a parallel tale of unwelcome advances and comments unfolded -
Disturbing allegations of sexual harassment in Antarctica leveled at noted scientist
Two women allege their team leader bullied them at remote research sites years ago. Now they are taking action
